Leonardus H.t. van der Ploeg, Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 15,000 shares at $25.38 ($381K) on 2019-05-28, disclosed to the SEC on 2019-05-30.
Open-market sale of $381k RYTM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.38 | 10,000 | $254K | 66.6% |
| 2 | $25.51 | 5,000 | $128K | 33.4% |
| Total | $25.42 avg | 15,000 | $381K | 100% |
| Filing → |
| RYTM | SELL | 2018-11-06 | $1.1M | — | Filing → |
| RYTM | SELL | 2018-09-27 | $1.9M | — | Filing → |